Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT03447769
Status:
TERMINATED
Last Update Posted:
2024-10-09
First Post:
2018-02-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-19
First Submit QC Date:
None
Study First Post Date:
2018-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-27
Results First Submit QC Date:
None
Results First Post Date:
2024-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-01-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL